Use of Recombinant Factor VIIa in Symptomatic Intracerebral Hemorrhage Following Intravenous Thrombolysis
نویسندگان
چکیده
Symptomatic intracerebral hemorrhage (sICH) occurs in up to 7% of stroke patients treated with thrombolytic therapy. There are limited data on the effectiveness of the reversal agents used for intravenous tissue plasminogen activator related intracranial bleeds. We report a patient with sICH following intravenous thrombolysis whose intracerebral hemorrhage continued to expand despite treatment with platelets and cryoprecipitate, needing recombinant factor VIIa use for stabilization before surgical evacuation. Factor VIIa along with routine reversal agents following intravenous thrombolysis related sICH may further enhance clot stability and reduce the risk of hematoma expansion. It could be a bridge to definitive surgical management in those patients.
منابع مشابه
Safety and feasibility of intravenous thrombolytic therapy in Iranian patients with acute ischemic stroke
Background: Thrombolytic therapy is the only approved treatment for acute cerebral ischemia. The hemorrhagic transformation is the greatest complication of this treatment, which may occur after recanalization of occluded artery. The aim of this study was to determine factors associated with clinical improvement and worsening in patients with acute ischemic stroke treated with intravenous th...
متن کاملEditorial CLEAR Intraventricular Hemorrhage More Than a Glimmer of Hope
See related article, pages ●●●–●●●. Stroke unit care, intravenous thrombolysis, and endovascular treatment of acute ischemic stroke have changed stroke medicine dramatically. In the past decades, the chances of surviving acute ischemic stroke without severe handicap have increased substantially for the majority of stroke patients. However, the outlook for patients with intracerebral hemorrhage ...
متن کاملMore Than a Glimmer of Hope
See related article, pages 3009–3016. Stroke unit care, intravenous thrombolysis, and endovascular treatment of acute ischemic stroke have changed stroke medicine dramatically. In the past decades, the chances of surviving acute ischemic stroke without severe handicap have increased substantially for the majority of stroke patients. However, the outlook for patients with intracerebral hemorrhag...
متن کاملLetter by power regarding article, "Severe renal impairment is associated with symptomatic intracerebral hemorrhage after thrombolysis for ischemic stroke".
BACKGROUND AND PURPOSE Patients with renal impairment (RI) have an increased risk of both thrombotic and hemorrhagic events. We aimed to clarify whether RI increases the risk of intracerebral hemorrhage (ICH) after intravenous thrombolysis with recombinant tissue plasminogen activator. METHODS Patients who received intravenous thrombolysis with recombinant tissue plasminogen activator within ...
متن کاملSubtherapeutic international normalized ratio in warfarin-treated patients increases the risk for symptomatic intracerebral hemorrhage after intravenous thrombolysis.
BACKGROUND AND PURPOSE There is uncertainty whether warfarin-treated patients (despite international normalized ratio < 1.7) have increased risks of symptomatic intracerebral hemorrhage after intravenous thrombolysis. METHODS Vascular risk factors, stroke subtype, and outcome measures were compared between warfarin- and nonwarfarin-treated patients undergoing acute thrombolysis within 3 hours...
متن کامل